Viewing Study NCT00971932


Ignite Creation Date: 2025-12-24 @ 9:49 PM
Ignite Modification Date: 2025-12-25 @ 7:27 PM
Study NCT ID: NCT00971932
Status: COMPLETED
Last Update Posted: 2014-04-08
First Post: 2009-09-03
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Study of Cetuximab in Combination With Chemotherapy in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Sponsor: Merck KGaA, Darmstadt, Germany
Organization: